Waters Corporation Announces Successful Combination with BD's Biosciences and Diagnostic Solutions Waters Corporation has successfully merged with BD's Biosciences and Diagnostic Solutions, creating a global leader in life sciences with innovative technologies and market expansion.

Waters Corporation Announces Successful Combination with BD's Biosciences and Diagnostic Solutions #USA #Milford #Waters_Corporation #Diagnostic_Solutions #BD_Biosciences

Meridian Bioscience Launches Innovative Stable qPCR Master Mixes, Revolutionizing Diagnostics Meridian Bioscience introduces groundbreaking liquid qPCR master mixes, eliminating cold chain requirements and ensuring reliability for over 12 months at ambient temperatures.

Meridian Bioscience Launches Innovative Stable qPCR Master Mixes, Revolutionizing Diagnostics #United_States #Cincinnati #Diagnostic_Solutions #Meridian_Bioscience #qPCR_master_mix

Kenya's IVD Market Set to Achieve $68.66 Million by 2032 Amid Rising Demand and Government Support The Kenya IVD market is projected to hit $68.66 million by 2032, driven by infectious disease burden and enhanced healthcare initiatives.

Kenya's IVD Market Set to Achieve $68.66 Million by 2032 Amid Rising Demand and Government Support #Kenya #Nairobi #Diagnostic_Solutions #Infectious_Diseases #Kenya_IVD_Market

Anbio Biotechnology to Present Innovative Diagnostic Technologies at Medlab Middle East 2025 Anbio Biotechnology will showcase its groundbreaking in-vitro diagnostic solutions at Medlab Middle East 2025 in Dubai, enhancing healthcare outcomes.

Anbio Biotechnology to Present Innovative Diagnostic Technologies at Medlab Middle East 2025 #Dubai #UAE #Anbio_Biotechnology #Medlab_Middle_East #Diagnostic_Solutions